ARM
VASC

Adirondack Research & Management’s Vascular Solutions Inc VASC Stock Holding History

Adirondack Research & Management’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-19,986
Closed -$294K – 99
2013
Q2 		$294K Buy
+19,986
New +$314K 0.22% 88

Other funds holding VASC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ACMM
Arbor Capital Management (Minnesota) Minneapolis, Minnesota $190M AUM 10.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Adirondack Research & Management's VASC Position: Q3 2013 in Review

Adirondack Research & Management sold out of Vascular Solutions Inc (VASC) in Q3 2013, closing a stake of 19,986 shares — an estimated $294K sold.

Adirondack Research & Management first reported a position in VASC in Q2 2013 and held it in 1 quarter. The position peaked at $294K in Q2 2013. 86 funds tracked by Wall St. Rank hold VASC as of Q3 2013.

  • Adirondack Research & Management reported no remaining Vascular Solutions Inc position as of Q3 2013 after selling out during the quarter.
  • Adirondack Research & Management sold 19,986 Vascular Solutions Inc shares in Q3 2013, an estimated $294K.
  • Adirondack Research & Management first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 1 quarter.
  • Adirondack Research & Management's Vascular Solutions Inc position peaked at $294K in Q2 2013.
  • 86 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q3 2013.

Based on Adirondack Research & Management's 13F filing for Q3 2013, filed 6 Nov 2013.